For: | Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, Akkoc N. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World J Gastroenterol 2008; 14(18): 2912-2914 [PMID: 18473420 DOI: 10.3748/wjg.14.2912] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2912.htm |
Number | Citing Articles |
1 |
Rasha H. Bassyouni, Reham A. Dwedar, Eman M. Ezzat, Raghda N. Marzaban, Maha Hamdy Nassr, Laila Rashid. Elevated Cytomegalovirus and Epstein-Barr virus burden in rheumatoid arthritis: A true pathogenic role or just a coincidence. The Egyptian Rheumatologist 2019; 41(4): 255 doi: 10.1016/j.ejr.2019.03.003
|
2 |
Seo Young Kim, Daniel H. Solomon. Tumor necrosis factor blockade and the risk of viral infection. Nature Reviews Rheumatology 2010; 6(3): 165 doi: 10.1038/nrrheum.2009.279
|
3 |
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Cytomegalovirus subacute thyroiditis in a patient treated by infliximab for psoriatic arthritis. Joint Bone Spine 2016; 83(1): 109 doi: 10.1016/j.jbspin.2015.06.001
|
4 |
M. J. SHALE, C. H. SEOW, C. S. COFFIN, G. G. KAPLAN, R. PANACCIONE, S. GHOSH. Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2010; 31(1): 20 doi: 10.1111/j.1365-2036.2009.04112.x
|
5 |
Anzelika Rubina, Mihil Patel, Katie Nightingale, Martin Potts, Ceri A. Fielding, Simon Kollnberger, Betty Lau, Kristin Ladell, Kelly L. Miners, Jenna Nichols, Luis Nobre, Dawn Roberts, Terrence M. Trinca, Jason P. Twohig, Virginia-Maria Vlahava, Andrew J. Davison, David A. Price, Peter Tomasec, Gavin W. G. Wilkinson, Michael P. Weekes, Richard J. Stanton, Eddie C. Y. Wang. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. Proceedings of the National Academy of Sciences 2023; 120(33) doi: 10.1073/pnas.2303155120
|
6 |
Manola Comar, Serena Delbue, Loredana Lepore, Stefano Martelossi, Oriano Radillo, Luca Ronfani, Pierlanfranco D'Agaro, Pasquale Ferrante. Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2. Journal of Medical Virology 2013; 85(4): 716 doi: 10.1002/jmv.23525
|
7 |
S. Domm, J. Cinatl, U. Mrowietz. The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature. British Journal of Dermatology 2008; 159(6): 1217 doi: 10.1111/j.1365-2133.2008.08851.x
|
8 |
|
9 |
Dora Y. Ho, Kyle Enriquez, Ashrit Multani. Herpesvirus Infections Potentiated by Biologics. Infectious Disease Clinics of North America 2020; 34(2): 311 doi: 10.1016/j.idc.2020.02.006
|
10 |
Cloé Comarmond, Bertrand Wechsler, Patrice Cacoub, David Saadoun. Approaches to Immunosuppression in Behçet‘s Disease. Immunotherapy 2013; 5(7): 743 doi: 10.2217/imt.13.66
|
11 |
Renée M. Marchioni Beery, Joshua R. Korzenik. Treatment of Inflammatory Bowel Disease with Biologics. 2018; : 185 doi: 10.1007/978-3-319-60276-9_12
|
12 |
Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri, Petros P. Sfikakis. Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients. Seminars in Arthritis and Rheumatism 2011; 41(1): 61 doi: 10.1016/j.semarthrit.2010.09.002
|
13 |
J. Correia, A. Campar, C. Ferrão, S. Silva, C. Vasconcelos. Infection and Autoimmunity. 2015; : 759 doi: 10.1016/B978-0-444-63269-2.00055-6
|
14 |
Justina Wei Lynn Tan, Hwee Siew Howe, Hiok Hee Chng. Ovarian Vein Thrombosis in Behçet Disease. JCR: Journal of Clinical Rheumatology 2012; 18(2): 89 doi: 10.1097/RHU.0b013e318247c187
|
15 |
Gulen Hatemi, Hasan Yazici. Behçet’s syndrome and micro-organisms. Best Practice & Research Clinical Rheumatology 2011; 25(3): 389 doi: 10.1016/j.berh.2011.05.002
|
16 |
Muhammed Sherid, Eli D. Ehrenpreis. Types of Colitis Based on Histology. Disease-a-Month 2011; 57(9): 457 doi: 10.1016/j.disamonth.2011.05.004
|
17 |
Christian Michaux, Philippe Morlat, Fabrice Bonnet. Infections à cytomégalovirus et autres viroses du groupe herpès au cours des maladies systémiques. La Presse Médicale 2010; 39(1): 34 doi: 10.1016/j.lpm.2009.04.005
|
18 |
Moe Kato, Shin Lee, Tetsuji Morishita, Kei Fujita, Atsushi Tagami, Hiroshi Araki, Jun-ichi Sugihara. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab. Journal of Infection and Chemotherapy 2022; 28(6): 823 doi: 10.1016/j.jiac.2022.01.018
|
19 |
Ondrej Hradsky, Ivana Copova, Kristyna Zarubova, Marianna Durilova, Jiri Nevoral, Miroslav Maminak, Petr Hubacek, Jiri Bronsky. Seroprevalence of Epstein–Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(11): 3399 doi: 10.1007/s10620-015-3764-z
|
20 |
Fatemeh Dabbagh, Afshin Borhani Haghighi, Younes Ghasemi. Behcet’s disease: from heat shock proteins to infections. Asian Biomedicine 2014; 8(2): 139 doi: 10.5372/1905-7415.0802.274
|
21 |
R. Cavallo. The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy. Clinical Microbiology and Infection 2011; 17(12): 1781 doi: 10.1111/j.1469-0691.2011.03678.x
|
22 |
Daniel Sánchez-Cano, José Luis Callejas-Rubio, Ricardo Ruiz-Villaverde, Raquel Ríos-Fernández, Norberto Ortego-Centeno. Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/286857
|
23 |
I. Marie, E. Guglielmino. Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFα. La Revue de Médecine Interne 2010; 31(5): 353 doi: 10.1016/j.revmed.2009.04.010
|
24 |
Felix Braun, Nadja Rifaie, Dieter C. Broering, Matthias Behrend. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 2010; 32: 675 doi: 10.1016/S0378-6080(10)32037-X
|
25 |
M. J. Shale. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. British Medical Bulletin 2009; 92(1): 61 doi: 10.1093/bmb/ldp036
|
26 |
Saied Ghorbani, Davod Javanmard, Seyed Jalal Kiani, Ahmad Tavakoli, Somayeh Sadat Moochani, Seyed Hamid Reza Monavari. No evidence of Human Cytomegalovirus infection among Behcet's Patients. Iranian Journal of Medical Microbiology 2020; 14(2): 133 doi: 10.30699/ijmm.14.2.133
|
27 |
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub, David Saadoun. Biotherapies in Behçet's disease. Autoimmunity Reviews 2014; 13(7): 762 doi: 10.1016/j.autrev.2014.01.056
|
28 |
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 2018; 16(10): 781 doi: 10.1080/14787210.2018.1521270
|
29 |
Pierre Charles, Felix Ackermann, Gaelle Burdy, Olivier Blétry, Jacques Leport, Jean Emmanuel Kahn. Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab. Scandinavian Journal of Gastroenterology 2010; 45(4): 509 doi: 10.3109/00365520903583871
|
30 |
Haoting Zhan, Linlin Cheng, Haolong Li, Yongmei Liu, Yuan Huang, Xiaomeng Li, Songxin Yan, Yongzhe Li. Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet’s disease by leveraging gene microarray data. Immunologic Research 2023; 71(6): 860 doi: 10.1007/s12026-023-09398-w
|
31 |
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Thyroïdite subaiguë de De Quervain à cytomégalovirus chez un patient traité par infliximab pour un rhumatisme psoriasique. Revue du Rhumatisme 2015; 82(5): 344 doi: 10.1016/j.rhum.2015.01.002
|
32 |
C. Comarmond, B. Wechsler, P. Cacoub, D. Saadoun. Traitement de la maladie de Behçet. La Revue de Médecine Interne 2014; 35(2): 126 doi: 10.1016/j.revmed.2013.12.003
|